A p.Arg499His Mutation in SPAST Is Associated with Infantile Onset Ascending Spastic Paralysis Complicated with Dysarthria and Anarthria

Abstract

The complication of anarthria in hereditary spastic paraplegia (HSP) patients has been reported to result from mutations in either ALS2 or FA2H. Here, we present a case of a 12-year-old boy with hereditary spastic paralysis and anarthria associated with a SPAST mutation. Initial presentation was at 14 months of age, when the patient experienced leg stiffness. At 3 years of age, he could speak well using sentences. At 9 years of age, he was found to have dysarthria and had difficulty writing. At 12 years of age, the ability to speak was lost. The patient could not vocalize any words, despite contraction of his neck and respiratory muscles during attempted vocalization. Additionally, the patient has never walked independently in his life. Considering these symptoms, we diagnosed him as having infantile onset ascending hereditary spastic paralysis (IAHSP) complicated with anarthria. By whole-exome sequencing, we discovered a heterozygous SPAST mutation c.1496G > A (p.Arg499His), which was not found in the parents and is probably de novo. This mutation was already repeatedly described with similar phenotype. Our results suggest that the p.Arg499His mutation in SPAST should be considered as a differential diagnosis in IAHSP.

Keywords

anarthria - dysarthria - ascending spastic paralysis - SPAST

• References

• 1 Blackstone C, O'Kane CJ, Reid E. Hereditary spastic paraplegias: membrane traffic and the motor pathway. Nat Rev Neurosci 2011; 12 (01) 31-42
• 2 Schüle R, Wiethoff S, Martus P. , et al. Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients. Ann Neurol 2016; 79 (04) 646-658
• 3 Eymard-Pierre E, Lesca G, Dollet S. , et al. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet 2002; 71 (03) 518-527
• 4 Lesca G, Eymard-Pierre E, Santorelli FM. , et al. Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families. Neurology 2003; 60 (04) 674-682
• 5 de Souza PV, Bortholin T, Naylor FG, de Rezende Pinto WB, Oliveira AS. Infantile-onset ascending spastic paraplegia phenotype associated with SPAST mutation. J Neurol Sci 2016; 371: 34-35
• 6 McDermott CJ, Burness CE, Kirby J. , et al; UK and Irish HSP Consortium. Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology 2006; 67 (01) 45-51
• 7 Kara E, Tucci A, Manzoni C. , et al. Genetic and phenotypic characterization of complex hereditary spastic paraplegia. Brain 2016; 139 (Pt 7): 1904-1918
• 8 Zaki MS, Selim L, Mansour L. , et al. Mutations in FA2H in three Arab families with a clinical spectrum of neurodegeneration and hereditary spastic paraparesis. Clin Genet 2015; 88 (01) 95-97
• 9 Gillespie MK, Humphreys P, McMillan HJ, Boycott KM. Association of early-onset spasticity and risk for cognitive impairment with mutations at amino acid 499 in SPAST. J Child Neurol 2018; 33 (05) 329-332
• 10 Polymeris AA, Tessa A, Anagnostopoulou K. , et al. A series of Greek children with pure hereditary spastic paraplegia: clinical features and genetic findings. J Neurol 2016; 263 (08) 1604-1611
• 11 Park SY, Ki CS, Kim HJ. , et al. Mutation analysis of SPG4 and SPG3A genes and its implication in molecular diagnosis of Korean patients with hereditary spastic paraplegia. Arch Neurol 2005; 62 (07) 1118-1121
• 12 Depienne C, Tallaksen C, Lephay JY. , et al. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet 2006; 43 (03) 259-265